Freestone Capital Holdings LLC cut its stake in The Allstate Corporation (NYSE:ALL – Free Report) by 9.4% in the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 19,130 shares of the insurance provider’s stock after selling 1,986 shares during the quarter. Freestone Capital Holdings LLC’s holdings in Allstate were worth $3,851,000 as of its most recent filing with the Securities & Exchange Commission.
A number of other large investors have also made changes to their positions in ALL. Vanguard Group Inc. raised its stake in Allstate by 0.5% during the 1st quarter. Vanguard Group Inc. now owns 32,800,086 shares of the insurance provider’s stock worth $6,791,914,000 after acquiring an additional 164,662 shares during the period. Price T Rowe Associates Inc. MD lifted its holdings in Allstate by 25.4% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 11,709,610 shares of the insurance provider’s stock worth $2,424,710,000 after buying an additional 2,374,684 shares in the last quarter. GQG Partners LLC raised its position in Allstate by 2.1% in the 1st quarter. GQG Partners LLC now owns 4,405,701 shares of the insurance provider’s stock valued at $912,288,000 after purchasing an additional 89,185 shares in the last quarter. Boston Partners increased its position in shares of Allstate by 613.9% in the 1st quarter. Boston Partners now owns 2,482,654 shares of the insurance provider’s stock valued at $512,627,000 after purchasing an additional 2,134,893 shares during the last quarter. Finally, Goldman Sachs Group Inc. lifted its holdings in Allstate by 27.2% during the 1st quarter. Goldman Sachs Group Inc. now owns 2,328,070 shares of the insurance provider’s stock worth $482,073,000 after buying an additional 497,982 shares during the last quarter. 76.47% of the stock is currently owned by institutional investors.
Allstate Price Performance
NYSE:ALL opened at $191.71 on Monday. The firm has a market cap of $50.52 billion, a PE ratio of 9.01, a price-to-earnings-growth ratio of 0.69 and a beta of 0.38. The company has a quick ratio of 0.43, a current ratio of 0.43 and a debt-to-equity ratio of 0.37. The Allstate Corporation has a 12 month low of $176.00 and a 12 month high of $215.70. The company’s 50-day moving average price is $202.56 and its two-hundred day moving average price is $201.12.
Wall Street Analyst Weigh In
Check Out Our Latest Report on Allstate
Allstate Profile
The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.
Featured Stories
- Five stocks we like better than Allstate
- High Dividend REITs: Are They an Ideal Way to Diversify?
- 3 Safe and Steady Stocks for Any Market
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- Is Lemonade Stock Set for a Big Squeeze After Earnings?
- Best Stocks Under $10.00
- Caterpillar Stock Could Top $650 by Year’s End
Want to see what other hedge funds are holding ALL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Allstate Corporation (NYSE:ALL – Free Report).
Receive News & Ratings for Allstate Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allstate and related companies with MarketBeat.com's FREE daily email newsletter.
